Jackeline
Agorreta Arrazubi
Publications dans lesquelles il/elle collabore avec Jackeline Agorreta Arrazubi (11)
2022
-
DSTYK inhibition increases the sensitivity of lung cancer cells to T cell-mediated cytotoxicity
The Journal of experimental medicine, Vol. 219, Núm. 12
-
Two cell line models to study multiorganic metastasis and immunotherapy in lung squamous cell carcinoma
DMM Disease Models and Mechanisms, Vol. 15, Núm. 1
2019
-
Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer
International Journal of Cancer, Vol. 145, Núm. 7, pp. 1991-2001
2018
-
A novel protein-based prognostic signature improves risk stratification to guide clinical management in early-stage lung adenocarcinoma patients
Journal of Pathology, Vol. 245, Núm. 4, pp. 421-432
2017
-
Impaired HLA class I antigen processing and presentation as a mechanism of acquired resistance to immune checkpoint inhibitors in lung cancer
Cancer Discovery, Vol. 7, Núm. 12, pp. 1420-1435
2016
-
Successful immunotherapy against a transplantable mouse squamous lung carcinoma with anti-PD-1 and anti-CD137 monoclonal antibodies
Journal of Thoracic Oncology, Vol. 11, Núm. 4, pp. 524-536
2014
-
TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
British Journal of Cancer, Vol. 110, Núm. 6, pp. 1545-1551
2013
-
Investigation of complement activation product C4d as a diagnostic and prognostic biomarker for lung cancer
Journal of the National Cancer Institute, Vol. 105, Núm. 18, pp. 1385-1393
-
Phosphorylated tubulin adaptor protein CRMP-2 as prognostic marker and candidate therapeutic target for NSCLC
International Journal of Cancer, Vol. 132, Núm. 9, pp. 1986-1995
2010
-
TGFBI expression is associated with a better response to chemotherapy in NSCLC
Molecular Cancer, Vol. 9